EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieÄquivalenzstudieOpen Access · CC BY-NC 4.0

Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study

Romana Kupsa, Alexandra Gruber-Wackernagel, Angelika Hofer, Franz Quehenberger, Peter Wolf, Franz J Legat

Acta Dermato-Venereologica · 2023

DOI: 10.2340/actadv.v103.9403 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Dermato-Venereologica, 2023. Verfasst von Romana Kupsa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Ultraviolet Therapy, Psoriasis, Dermatitis, Atopic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Narrowband-ultraviolet B has shown increased efficacy over broadband-ultraviolet B in pruritic skin diseases, such as psoriasis and atopic dermatitis. In patients with chronic pruritus, e.g. in end-stage renal disease, broadband-ultraviolet B is recommended, but narrowband-ultraviolet B has also shown efficacy in reducing pruritus. This randomized, single blinded, non-inferiority study investigated the effects of narrowband-ultraviolet B compared with broadband-ultraviolet B. Patients with chronic pruritus were treated with either broadband- or narrowband-UVB 3 times a week for 6 weeks and clinical response was monitored. Pruritus, sleep disturbance, and the patients’ subjective overall response to treatment were evaluated by the patients on a visual analogue scale (0–10). Skin excoriations were evaluated by investigators on a 4-point scale (0–3). Both phototherapeutic modalities showed significant antipruritic activity (itch reduction 48% and 66.4%, respectively) by broadband-ultraviolet B and narrowband-ultraviolet B. Narrowband-ultraviolet B proved to be not inferior to broadband-ultraviolet B in treating pruritus in patients with chronic pruritus, assuming a 20% non-inferiority margin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ultraviolet TherapyPsoriasisDermatitis, AtopicHumansPruritusData CollectionTreatment Outcome

Autor:innen und Institutionen

  • Department of Dermatology, Medical University of Graz, Graz, Austria.
  • Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
  • Department of Dermatology, Medical University of Graz, Graz, Austria. franz.legat@medunigraz.at.

Zitieren

APA

Kupsa, R., Gruber-Wackernagel, A., Hofer, A., Quehenberger, F., Wolf, P., & Legat, F. J. (2023). Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v103.9403

Vancouver

Kupsa R, Gruber-Wackernagel A, Hofer A, Quehenberger F, Wolf P, Legat FJ. Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study. Acta Dermato-Venereologica. 2023. doi:10.2340/actadv.v103.9403

BibTeX
@article{Kupsa2023,
  author = {Kupsa, Romana and Gruber-Wackernagel, Alexandra and Hofer, Angelika and Quehenberger, Franz and Wolf, Peter and Legat, Franz J},
  title = {Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study},
  journal = {Acta Dermato-Venereologica},
  year = {2023},
  doi = {10.2340/actadv.v103.9403}
}
Kostenlos starten →